G M D C (GMDCLTD)

FairStock Score: 72/100 — STEADY

Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Near-zero leverage with D/E of 0.04 provides strong financial resilience
• Consistent profitability: ROE 15.42%, ROCE 14.06%, and positive free cash flow of ₹251 Cr
• High promoter holding of 74% aligns management with minority shareholders
• Good long-term growth record with 5-year revenue CAGR of 16.54%
• Latest quarter net margin of about 23% shows current pricing power

Concerns

• Valuation is rich: P/E of 28.31 and P/B of 3.39 leave a negative margin of safety versus Graham Number of ₹375.56
• Revenue declined 6.72% while profit jumped 52.87%, suggesting earnings may be price-driven or one-off in nature
• DCF intrinsic value of ₹39.10 is far below the market price, signalling potential overvaluation under conservative assumptions
• Negative EV/EBITDA of -44.01 makes standard earnings-based valuation comparisons unreliable

AI Analysis

Reading GMDC, I am reminded that a decent business can still be a poor investment at the wrong price. There is much to like on the balance sheet: debt-equity of just 0.04 and promoter holding of 74% mean financial risk is low and shareholder alignment is strong. Return on equity of 15.42% and ROCE of 14.06% are respectable, though not exceptional. The 5-year revenue CAGR of 16.54% shows good long-term growth, but the latest sales figure is down 6.72%. That immediately makes me pause. Profit growth of 52.87% while revenue contracts usually means prices or other income are doing heavy lifting, not durable volume growth. The latest quarter shows net profit of ₹133 Cr on sales of ₹579 Cr, a remarkable 23% margin, but this is exactly the point in the commodity cycle where margins look best. Mr. Market is asking ₹682.70, or 28.31 times earnings and 3.39 times book value. Graham's Number is ₹375.56, implying a negative margin of safety of 51.6%. The long-term DCF value of ₹39.10 is far below the price, and while no single DCF is gospel, it reinforces that I would need a much lower price. Free cash flow of ₹251 Cr is helpful, but it is only about 1.4% of the market cap. The dividend yield of 1.77% is acceptable but not a substitute for valuation discipline. Altman Z of 2.78 and Piotroski F-score of 6/9 suggest moderate financial health. As Buffett says, it is far better to buy a wonderful company at a fair price; here I see a decent cyclical at an uncomfortable price. I would wait for better margin of safety before acting.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer